Poppitt Sally D
Human Nutrition Unit, Department of Medicine, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Front Nutr. 2020 Dec 8;7:574725. doi: 10.3389/fnut.2020.574725. eCollection 2020.
Cow's milk and dairy products derived from this complex food source have long been proposed as beneficial to human health, yet underlying clinical evidence of direct benefit continues to raise controversy. Limited evidence supports positive cardiometabolic effects of a number of dairy macro- and micronutrient components including whey protein and casein, unsaturated fats, milk fat globule membrane (MFGM) and polar phospholipids, vitamin D and calcium, in addition to non-bovine components including bacterial and yeast probiotics. More controversial remain lipid components fats, including vaccenic acid, palmitoleic acid, and conjugated linoleic acid (CLA), plus medium-chain and odd-chain dairy fats. New evidence is rapidly identifying multiple pathways by which these dairy nutrients may effect health. Processing, including fermentation and homogenization, may also have positive effects. Conversely, the high saturated fat content of dairy has long raised concern, aligned with international guidelines to minimize dietary intake of animal-origin saturated fatty acids (SFA) to achieve better cardiometabolic health. However, led in part by observational studies and meta-analyses showing dairy to have no or even an inverse association with cardiometabolic health, evidence from randomized controlled trials (RCTs) has been scrutinized over the last 5 years, and focus on low-fat dairy has been challenged. Recent evidence supports the hypothesis that adverse effects of SFAs on metabolic health may be ameliorated when these fats are consumed within a complex matrix such as milk, cheese or yogurt, and that dairy food categories may influence outcomes as much as total fat content. For example, yogurt and high-fat, high-SFA cheese have a negative association with risk of type 2 diabetes (T2D) in many, not all, published trials. However, large sample dairy RCTs of long duration with CVD or T2D incidence as primary endpoints are lacking. This is a clear research gap, with these clinical studies required if a causative link between dairy and improved cardiometabolic health is to be confirmed and in turn promoted through dietary guidelines. Current advisories from national guidance groups such as American Heart Association (AHA) and European Society of Cardiology (ESC) continue to promote consumption of low-fat dairy products, whilst liquid milk and yogurt remain part of nutrition guidelines from joint American Diabetes Association (ADA)/European Association for Study of Diabetes (EASD) reports, and as part of a "no-one-size-fits-all" answer to diet and T2D by the ADA in their most recent 2019 Consensus Report.
长期以来,源自这种复杂食物来源的牛奶及奶制品一直被认为对人体健康有益,但直接益处的潜在临床证据仍存在争议。有限的证据支持一些乳制品的大量和微量营养成分具有积极的心脏代谢作用,这些成分包括乳清蛋白和酪蛋白、不饱和脂肪、乳脂肪球膜(MFGM)和极性磷脂、维生素D和钙,此外还包括非牛成分,如细菌和酵母益生菌。更具争议的是脂质成分,包括反式油酸、棕榈油酸和共轭亚油酸(CLA),以及中链和奇链乳脂肪。新证据正在迅速确定这些乳制品营养成分可能影响健康的多种途径。加工,包括发酵和均质化,也可能产生积极影响。相反,乳制品中高饱和脂肪含量长期以来一直引发关注,这与国际准则一致,即尽量减少动物源性饱和脂肪酸(SFA)的饮食摄入量,以实现更好的心脏代谢健康。然而,部分受观察性研究和荟萃分析的影响,这些研究表明乳制品与心脏代谢健康无关联甚至呈负相关,过去5年对随机对照试验(RCT)的证据进行了审查,对低脂乳制品的关注受到了挑战。最近的证据支持这样一种假设,即当这些脂肪在牛奶、奶酪或酸奶等复杂基质中食用时,SFA对代谢健康的不利影响可能会得到改善,而且乳制品类别对结果的影响可能与总脂肪含量一样大。例如,在许多(并非所有)已发表的试验中,酸奶以及高脂肪、高SFA奶酪与2型糖尿病(T2D)风险呈负相关。然而,缺乏以心血管疾病(CVD)或T2D发病率为主要终点的长期大样本乳制品RCT。这是一个明显的研究空白,如果要证实乳制品与改善心脏代谢健康之间的因果关系,并进而通过饮食指南加以推广,就需要进行这些临床研究。美国心脏协会(AHA)和欧洲心脏病学会(ESC)等国家指导小组目前的建议继续提倡食用低脂乳制品,而液态奶和酸奶仍然是美国糖尿病协会(ADA)/欧洲糖尿病研究协会(EASD)联合报告中的营养指南的一部分,并且在ADA 2019年最新共识报告中,作为针对饮食和T2D的“一刀切”答案的一部分。